Patent Awarded

Patent Number Title Inventors Date
1 10676518 A4B2 nicotinic acetylcholine receptors with reduced or increased
nicotine sensitivity and transgenic mouse model for the same.
Caballero-Rivera; Daniel, Biaggi-Labiosa; Nilza M, Aviles-Pagan; Emir,
Lasalde-Dominicci; José A.
April 2016
2 10,155,221 High-throughput crystallographic screening device and method for
crystalizing membrane proteins using a sub physiological resting
membrane potential across a lipid matrix of variable composition.
Lasalde-Dominicci; Jose A., Quesada-Gonzalez; Orestes,
Rodriguez-Cordero; Josue, Baez-Pagan; Carlos
Dec 2018
3 10,358,475 High-throughput crystallographic screening device and method for
crystalizing membrane proteins using a sub physiological resting
membrane potential across a lipid matrix of variable composition.
Jose A. Lasalde-Dominicci, Orestes Quesada-Gonzalez, Josue
Rodriguez-Cordero, Carlos Baez-Pagan
July 2019
4 15/996,946 High-throughput crystallographic screening device and method for
crystalizing membrane proteins using a sub physiological resting
membrane potential across a lipid matrix of variable composition.
Jose A. Lasalde-Dominicci Jan 2022
5 11,717,819 High-throughput crystallographic screening device and method for
crystalizing membrane proteins using a sub physiological resting
membrane potential across a lipid matrix of variable
composition-Consolidated
Jose A. Lasalde-Dominicci August 2023

Patent Applications


1. Title:
A Method of Treating and Reducing Inflammation and HIV-associated neurocognitive disorders (HAND) on HIV+ Subjects.
Application number:
14/469,517


 

2. Title: A Method for Predicting Increased Risk of Suffering Statin-induced Adverse Drug Reactions.

Application number: 13/540,598


 

3. Title: α4β2 nicotinic acetylcholine receptors with reduced or increased nicotine sensitivity.

Application number: 62/153,660


 

4. Title: High-throughput crystallographic screening device and method for membrane proteins

  Application number: 62/356,266


New patent applications in 2023

 

1 – A continuation-in-part (CIP) patent application entitled “A lithographic RMP@LMx V.2 and V3 device for membrane protein crystallization” for the protection of a Lithographic version device filed on April 11, 2023.

 


 

2 – A Provisional Patent application. Filing Receipt – Serial No. 63459620 (Guanosine Microparticles for Vaccine Optimization, Method of Synthesis and Applications Thereof) filed on April 14 2023.